Home self-administration of vaginal misoprostol for medical abortion at 5063 days compared with gestation of below 50 days

By Kopp Kallner H.   Fiala C.   Stephansson O.   Gemzell-Danielsson K.  

Human Reproduction, Vol. 25, Iss. 5, 2010-05 ,pp. : 1153-1157

Oxford University Press

Access to resources Recommend Favorite

Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial

By von Hertzen Helena   Piaggio Gilda   Wojdyla Daniel   Huong Nguyen Thi My   Marions Lena   Okoev Georgy   Khomassuridze Archil   Kereszturi Attila   Mittal Suneeta   Nair Rajasekharan   Daver Rekha   Pretnar-Darovec Alenka   Dickson Kim   Hinh Nguyen Duc   Bao Nguyen Huy   Tuyet Hoang Thi Diem   Peregoudov Alexandre  

Human Reproduction, Vol. 24, Iss. 1, 2009-01 ,pp. : 106-112

Oxford University Press

Access to resources Recommend Favorite

Pregnancy. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?

By Singh K.   Fong Y.F.   Prasad R.N.V.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1635-1637

Oxford University Press

Access to resources Recommend Favorite

Pregnancy and obstetrics. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability

By Ngai S.W.   Tang O.S.   Chan Y.M.  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1159-1162

Oxford University Press

Access to resources Recommend Favorite

Fertility control. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation

By Bartley Julia   Brown Audrey   Elton Rob  

Human Reproduction, Vol. 16, Iss. 10, 2001-10 ,pp. : 2098-2102

Oxford University Press

Access to resources Recommend Favorite